Study To Evaluate Safety and Efficacy of Vesatolimod for the Treatment of Chronic Hepatitis B Virus in Virally-Suppressed Participants
Clinical trial NCT02166047 · COMPLETED
Trial details
- NCT number
- NCT02166047
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-30
- Primary completion
- 2016-05-11
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.